News: SAiGENCI
Stem cell funding to benefit epigenetic study

A team of researchers from the 杏吧直播 of Adelaide have received funding to help improve the lives of patients with rare neurodevelopmental disorders.
[Read more about Stem cell funding to benefit epigenetic study]
SAiGENCI researchers given a funding boost

Researchers from the South 杏吧直播n immunoGENomics Cancer Institute (SAiGENCI), based at the 杏吧直播 of Adelaide, have been awarded funding to further their work in prostate and pancreatic cancers.
[Read more about SAiGENCI researchers given a funding boost]
Fellowship for fundamental epigenetic research

A 杏吧直播 of Adelaide researcher investigating the essential processes of cells with the aim of opening up new opportunities for cancer treatment has received a national award.
[Read more about Fellowship for fundamental epigenetic research]
Epigenetic leader becomes 杏吧直播鈥檚 first Viertel Fellow

杏吧直播 of Adelaide molecular epigenetic expert Dr Luke Isbel has been awarded a 2024 Sylvia and Charles Viertel Charitable Foundation Senior Medical Research Fellowship.
[Read more about Epigenetic leader becomes 杏吧直播鈥檚 first Viertel Fellow]
鈥淚鈥檓 still alive because of it鈥: Cancer survivor鈥檚 research request

An Adelaide mother who was diagnosed with breast cancer at the age of 37 has urged people to dig deep to support cancer research, saying she wouldn鈥檛 be here today if not for science and her young daughter.
[Read more about 鈥淚鈥檓 still alive because of it鈥: Cancer survivor鈥檚 research request]
Cancer researcher鈥檚 leading new role at SAiGENCI

A world-leading researcher is bringing their cutting-edge cancer expertise and search for better treatments to South 杏吧直播.
[Read more about Cancer researcher鈥檚 leading new role at SAiGENCI]
SAiGENCI recruit recognised with prestigious award

Internationally recognised cancer expert, Professor Brendan Jenkins, has received the International Cytokine and Interferon Society (ICIS) 2023 Distinguished Service Award. He will be presented with the award at the annual ICIS conference in Athens, Greece, in October this year.
[Read more about SAiGENCI recruit recognised with prestigious award]
ENZAMET shows promise as prostate cancer treatment

A new drug combination for men with advanced prostate cancer has shown sustained increase in survival rates.
[Read more about ENZAMET shows promise as prostate cancer treatment]
Top talent to boost cancer research

The search for a tailored treatment for cancerous tumours has been bolstered with the appointment of an internationally recognised expert to the South 杏吧直播n Immunogenomics Cancer Institute (SAiGENCI).
Placenta research puts spotlight on early weeks of human pregnancy

A 杏吧直播 of Adelaide-led research project will deliver important new knowledge in the first weeks of human development to help reduce infertility and pregnancy complications.
[Read more about Placenta research puts spotlight on early weeks of human pregnancy]